IRIS
BONDANZA, ATTILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.122
EU - Europa 3.810
NA - Nord America 2.420
SA - Sud America 1.203
AF - Africa 96
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.308
RU - Federazione Russa 2.227
SG - Singapore 1.582
CN - Cina 1.221
BR - Brasile 978
SE - Svezia 580
HK - Hong Kong 516
VN - Vietnam 412
IT - Italia 320
FR - Francia 200
DE - Germania 135
AR - Argentina 95
IN - India 88
GB - Regno Unito 75
BD - Bangladesh 56
JP - Giappone 54
EC - Ecuador 48
FI - Finlandia 48
AT - Austria 46
CA - Canada 46
MX - Messico 42
ZA - Sudafrica 37
IE - Irlanda 35
NL - Olanda 35
IQ - Iraq 34
ID - Indonesia 31
PL - Polonia 23
CO - Colombia 22
PY - Paraguay 22
MA - Marocco 19
TR - Turchia 18
UA - Ucraina 16
UZ - Uzbekistan 14
ES - Italia 13
IL - Israele 13
PK - Pakistan 12
SA - Arabia Saudita 11
DZ - Algeria 10
VE - Venezuela 10
CL - Cile 9
TN - Tunisia 9
UY - Uruguay 9
EG - Egitto 8
AU - Australia 7
IR - Iran 7
PE - Perù 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KE - Kenya 6
LT - Lituania 6
CH - Svizzera 5
HU - Ungheria 5
JM - Giamaica 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
PH - Filippine 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BE - Belgio 3
BH - Bahrain 3
GR - Grecia 3
MY - Malesia 3
NP - Nepal 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
LK - Sri Lanka 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
Totale 11.659
Salva come PNG Salva come JPEG
Città #
Singapore 570
Moscow 512
Hong Kong 510
Dallas 380
Ashburn 330
San Jose 271
Shanghai 250
Hefei 194
Lawrence 185
Princeton 185
Lauterbourg 161
Ho Chi Minh City 144
Beijing 136
New York 114
Milan 96
Hanoi 76
São Paulo 70
Los Angeles 46
Nuremberg 38
Rio de Janeiro 38
Dublin 34
Boardman 29
Orem 27
Helsinki 26
Chennai 23
Guangzhou 23
Santa Clara 23
Tokyo 23
Da Nang 22
Munich 22
Belo Horizonte 21
Johannesburg 21
Brasília 19
Phoenix 19
Quito 19
Guayaquil 18
Seattle 18
Warsaw 18
Brooklyn 17
Haiphong 17
Vienna 17
Biên Hòa 16
The Dalles 16
Turku 16
Curitiba 15
Montreal 15
Washington 14
Boston 12
Campinas 12
Frankfurt am Main 12
London 12
Poplar 12
Porto Alegre 12
Tashkent 12
Baghdad 11
Denver 11
Mexico City 11
Can Tho 10
Guarulhos 10
Hangzhou 10
Shenzhen 10
Shijiazhuang 10
Toronto 10
Ankara 9
Buenos Aires 9
Council Bluffs 9
Hải Dương 9
Salvador 9
Stockholm 9
Zhengzhou 9
Amsterdam 8
Fortaleza 8
Goiânia 8
Jiaxing 8
Manchester 8
Montevideo 8
Naples 8
Recife 8
Rome 8
Xi'an 8
Atlanta 7
Houston 7
Mumbai 7
Reston 7
Santo André 7
Tianjin 7
Volta Redonda 7
Asunción 6
Baku 6
Barnet 6
Bauru 6
Campos dos Goytacazes 6
Caxias do Sul 6
Ciudad del Este 6
Montes Claros 6
Nairobi 6
Nova Iguaçu 6
San Francisco 6
Belém 5
Bergamo 5
Totale 5.299
Salva come PNG Salva come JPEG
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 217
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 213
Loss of mismatched HLA in leukemia after stem-cell transplantation 182
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 161
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 151
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 147
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 146
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 134
Anti-beta 2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance 133
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 117
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 115
A dual role for genetically modified lymphocytes in cancer immunotherapy 110
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 108
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 108
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 107
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 107
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 102
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 101
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 96
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 95
Anti-beta 2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance 92
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 91
An apoptotic cell threshold for dendritic cell maturation and function. 91
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 89
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 88
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 88
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 86
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 85
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 84
Anti-phospholipid antibodies opsonize activated platelets for uptake by dendritic cells: relevance to epitope spreading in platelet autoimmunity. 82
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 82
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 80
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 78
Apoptotic cell-pulsed dendritic cells break tolerance and accelerate lupus in NZB/W F1 mice. 78
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 78
B- and T-cell interactions in graft-versus-host disease 78
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 77
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 77
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 75
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 75
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 74
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 72
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 71
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 71
Stability of human rapamycin-expanded CD4(+)CD25(+) T regulatory cells 70
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 70
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 69
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 68
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 68
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 66
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 65
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors 65
Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma 64
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 64
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 62
Use of IL-7 and IL-15 for the genetic modification of memory T lymphocytes 62
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 61
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 61
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 60
H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD 60
CD44v6 is associated with chemoresistance induced by bone marrow-derived mesenchymal stromal cells 60
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 60
Improving the safety of cell therapy with the TK-suicide gene. 59
CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer 59
Editing human lymphocytes specificity for safe and effective adoptive immunoterapy of leukemia 59
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens 58
Jon van Rood (1926-2017) 58
Clinical pharmacology of CAR-T cells: linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 57
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 57
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4(+) T Cells 56
Overcoming the toxicity hurdles of genetically targeted T cells. 56
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 56
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 56
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4(+) and CD8(+) T-cell responses 55
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 55
uPA/uPAR system is active in immature dendritic cells derived from CD14(+)CD34(+) precursors and is down-regulated upon maturation 55
Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia 55
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 54
Immunostimulatory leukemic dendritic cells can efficiently expand leukemia-reactive T cells from HSCT donors 54
Naive-Derived Memory Stem T Cells: A Novel Promising Platform for Cancer Immune-Gene Therapy 53
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 53
Haploidentical HSCT: a 15-year experience at San Raffaele. 53
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation 53
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies 53
Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients 52
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 52
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 52
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 52
Progress and prospects: graft-versus-host disease 51
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 51
Harnessing CD1-restricted T cells for the immunotherapy of leukemia 51
Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia 51
Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors 51
Use of common gamma-chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes 51
Modulation of graft-versus-host disease induced by central memory suicide gene modified human T lymphocytes 50
Gene transfer of modified idiotype into dendritic cells for immunotherapy of non-Hodgkin lymphomas 50
Editing human lumphocyte specificity for safe and effective adoptive immunotherapy 50
Thymic renewal in adult leukaemia patients after haplodentical stem cell transplantation and infusion of suicide gene-modified donor T-cells 50
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 50
Totale 7.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 68 9 6 10 10 12 16 3 9
2022/20231.094 408 233 67 3 25 119 54 76 62 12 27 8
2023/2024567 26 22 49 52 50 114 59 51 8 30 22 84
2024/20252.647 306 30 34 113 71 186 309 218 477 373 258 272
2025/20267.222 582 626 718 1.231 511 222 604 523 1.993 212 0 0
Totale 11.750